Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Thermopylae Holdings Ltd | 10% Owner | 2025-03-11 | 343,631 | $2.16 | $742.24kBuy |
John S. Montalbano | Director | 2025-03-10 | 25,000 | $2.30 | $57.50kBuy |
John S. Montalbano | Director | 2025-03-06 | 60,000 | $2.34 | $140.58kBuy |
Carl L. G. Hansen | Chief Executive Officer | 2024-11-25 | 56,125 | $2.70 | $151.54kBuy |
Carl L. G. Hansen | Chief Executive Officer | 2024-09-20 | 56,125 | $2.70 | $151.54kBuy |
Thermopylae Holdings Ltd | 10% Owner | 2024-08-29 | 283,516 | $2.61 | $739.98kBuy |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Carl L. G. Hansen | 19.09% | 56,984,009 | $194.32M | Insider |
Thermopylae Holdings Ltd | 18.81% | 56,143,640 | $191.45M | Insider |
Baker Bros Advisors LP | 9.22% | 27,525,640 | $93.86M | Institution |
Ubs Am A Distinct Business Unit Of Ubs Asset Management Americas LLC | 5.25% | 15,671,063 | $53.44M | Institution |
John Hamer | 4.94% | 14,734,623 | $50.25M | Insider |
Capital World Investors | 4.48% | 13,361,096 | $45.56M | Institution |
Baillie Gifford Co | 3.75% | 11,195,832 | $38.18M | Institution |
Voya Investment Management LLC | 3.56% | 10,624,185 | $36.23M | Institution |
Ubs Group Ag | 1.70% | 5,082,183 | $17.33M | Institution |
Orbimed Advisors LLC | 1.40% | 4,180,768 | $14.26M | Institution |